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Aim: The RapidArc commissioning and Acceptance Testing program will test and ensure
accuracy in DMLC position, precise dose-rate control during gantry rotation and accurate
control of gantry speed.
Background: Recently, we have upgraded our linear accelerator capable of performing IMRT
which was functional from 2007 with image guided RapidArc facility. The installation of
VMAT in the existing linear accelerator is a tedious process which requires many quality
assurance procedures before the proper commissioning of the facility and these procedures
are discussed in this study.
Materials and methods: Output of the machine at different dose rates was measured to ver-
ify  its consistency at different dose rates. Monitor and chamber linearity at different dose
rates were checked. DMLC QA comprising of MLC transmission factor measurement and
dosimetric leaf gap measurements were performed using 0.13 cm3 and 0.65 cm3 Farmer
type ionization chamber, dose 1 dosimeter, and IAEA 30 cm × 30 cm × 30 cm water phan-
tom.  Picket fence test, garden fence test, tests to check leaf positioning accuracy due to
carriage movement, calibration of the leaves, leaf speed stability effects due to the acceler-
ation  and deceleration of leaves, accuracy and calibration of leaves in producing complex
ﬁelds, effects of interleaf friction, etc. were veriﬁed using EDR2 therapy ﬁlms, Vidar scanner,
Omnipro accept software, amorphous silicon based electronic portal imaging device and
EPIQA software.1–8
Results: All the DMLC related quality assurance tests were performed and evaluated by ﬁlmdosimetry, portal dosimetry and EPIQA.7
Conclusion: Results conﬁrmed that the linear accelerator is capable of performing accurateVMAT.
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.  Background
ur institute has been functional since 2007 with a Varian
inear accelerator capable of performing IMRT with 6 and
5 MV photons. Recently, we  have upgraded this existing linear
ccelerator with an Image  guided RapidArc facility. RapidArc
r volumetric modulated arc therapy is a novel treatment
lanning and delivery system that has recently been made
vailable for clinical use.
The idea of using a traditional linear accelerator gantry
or a rotational IMRT  treatment was ﬁrst suggested by Yu
t al. in 1995 as an alternative to tomotherapy, which neces-
itated specialized equipment and struggled with abutment
roblems between treatment slices at that time. Yu’s alterna-
ive was called intensity modulated arc therapy (IMAT) and
tilized a large ﬁeld size, traditional linear accelerator, contin-
ous gantry rotation, and dynamic MLC. To create an intensity
istribution, IMAT  was delivered in multiple overlapping arcs.
ach arc delivered only one level of intensity; therefore, mul-
iple arcs were required for multiple levels of intensity. The
wo-dimensional intensity distribution at each angle was a
omposition of multiple radiation ﬁelds of uniform intensity
ith different shapes and sizes. Developments in rotational
elivery capabilities of traditional linear accelerators in the
ast few years, speciﬁcally variable dose rate and variable
antry speed, have sparked a new interest in rotational IMRT
elivery and IMAT.  Volumetric modulated arc therapy (VMAT)
as been developed using the basic principles of IMAT, coupled
ith these new machine capabilities.
VMAT  offers potential dosimetric and efﬁciency advan-
ages by being able to deliver modulated cone-beam radiation
rom a single or multiple arc. During a VMAT treatment, MLC
eaves dynamically shape the beam to treat the entire vol-
me  of the planning target volume (PTV) with every rotation,
nd the dose rate and/or gantry rotation speed is continu-
usly varied as the gantry of the linear accelerator rotates
round the patient. Three key components of VMAT rota-
ional delivery are dynamic MLC, variable dose rate and gantry
peed. The MLC  leaf speed is kept within a prespeciﬁed maxi-
um tolerance of 2.5 cm/s during the optimization. The gantry
peed is then maximized at 4.8◦/s unless the required MU
er degree exceeds the maximum dose rate of 400 MU/min,
n which case the gantry slows down to accommodate the
equired MU/degree. VMAT  treatments must use a dynamic
LC  because the beam is on during the entire treatment as
he gantry rotates around the patient. For VMAT treatment,
he MLC  leaves move as a function of gantry position, not time.
he leaves reposition according to where the gantry is located
n its rotation and each angle of rotation sees only one segment
haped by the MLC. In short, VMAT  delivery combines vary-
ng leaf motion with varying dose rate and/or gantry rotation
peed to modulate beam intensity.1–6
The introduction of advanced irradiation techniques into
 radiotherapy clinic requires extensive dose veriﬁcation
easures that go beyond current routine clinical practice.
morphous silicon electronic portal imaging devices (a-Si
PIDs) were originally designed for patient set-up veriﬁcation;
owever, their use has been extended to dose veriﬁcation over
he past few years, since portal images also contain dosimetrictherapy 1 8 ( 2 0 1 3 ) 286–297 287
information. EPID can be a powerful tool in the reduction of
treatment setup errors and the quality assurance and veriﬁca-
tion of complex treatments. Film imaging is time consuming
and labor intensive.
Portal imaging systems are therefore developed to provide
both geometrical and dosimetric information. Compared to
previous systems, the amorphous silicon-based EPID pro-
vides better quality portal images. The aS500 EPID consists
of a 1 mm Cu top plate, a 0.3 mm Gd oxysulphide phosphor
screen, and a 0.18 mm polyester reﬂector as an active ele-
ment. The light generated in the scintillator is detected by
a 40,330 cm2 (512 × 384 pixel, 0.78 mm × 0.78 mm pixel pitch)
array of amorphous-Si photodiodes. Each diode is connected
to a thin-ﬁlm transistor and can be read out separately. The
image acquisition system acquires images by scanning each
row of the detectors sequentially. By averaging a large number
of frames, an EPID can continuously scan the matrix of silicon
detectors during the irradiation of a ﬁeld, sum all acquired
frames and send an averaged image  to the console computer
upon completion of radiation delivery. A separate dose image
prediction algorithm Portal Dosimetry Image  Prediction (PDIP)
is part of the Eclipse Treatment Planning System. It converts
the pixel data to absolute dose.8–11
Several studies of dose–response characteristics have
shown that a-Si EPIDs are suitable for dose veriﬁcation. These
studies have shown that the pixel signal is approximately
linear with dose and can be converted to absolute dose by
measuring the response over a wide range of parameters. In
addition, the response of the a-Si EPID is stable within ±0.5%
over long periods, up to at least 2 years, provided there are no
electronic failures. EPID measurements are simple to perform
with minimum set-up requirements, they can be repeated
easily and digital data is obtained immediately, unlike ﬁlms
which require additional time for developing and digitizing.
Once an EPID is calibrated for a certain linac and energy,
EPID images can be immediately converted to absolute dose
images, whereas each ﬁlm batch requires a new calibration,
involving additional measurements. So, we  did all the 2D ﬂu-
ence measurements on ﬁlm as well as the EPID, so that once
we ﬁnished calibrating, we could use EPID for regular quality
assurance of VMAT.
Epiqa is a program that allows to convert a dosimetric
image  acquired by an EPID into a dose map  and to com-
pare the dose map  with a reference dose distribution. It is
possible to utilize Epiqa for veriﬁcation of static as well as
intensity modulated ﬁelds, including RapidArc® ﬁelds. The
portal dosimetry image  conversion to dose map  is based on
the GLAaS algorithm – an absolute dose calibration algorithm
for an amorphous silicon portal imager. The veriﬁcation with
EPIQA helps us to cross check the PDIP measurements.7–11
2.  Aim  of  the  study
In VMAT, there are three interrelated machine parameters that
are allowed to vary: the MLC leaf speed, the gantry speed and
the dose rate. The installation of VMAT in the existing linear
accelerator is a tedious process which requires many  qual-
ity assurance procedures before a proper commissioning of
the facility. For RapidArc, gantry was calibrated for continuous
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ed frFig. 1 – The graph obtain
rotation with changing dose rate and MLC  leaf positions. The
VMAT  commissioning and Acceptance Testing program will
test and ensure reliable system capabilities that are incremen-
tal to those of IMRT-DMLC. The three most important elements
are (1) accuracy in DMLC position, (2) precise dose-rate control
during gantry rotation and (3) accurate control of gantry speed.
The highlight of the study is that all the ﬂuence measure-
ment parameters are not only measured on ﬁlm but also on
the Electronic Portal Imaging Device (EPID) with Portal Dose
Image Prediction (PDIP) software and EPIQA software. So, the
efﬁciency of the latter software was evaluated and analyzed.
The advantage is that in the later stage, when performing
the machine speciﬁc and patient speciﬁc quality assurance
on everyday basis, the analysis can be done on the EPID and
evaluated using PDIP and EPIQA software which is simpler and
easier when compared to ﬁlm measurements.
3.  Materials  and  methods
The installation and quality assurance of this upgraded facil-
ity is a tedious process. After installation of VMAT,  output of
the machine at different dose rates was measured to verify
its consistency at different dose rates, monitor and cham-
ber linearity at different dose rates were checked, DMLC QA
Fig. 2 – Flatness and symmetry rom DLS measurements.
comprising of MLC transmission factor measurement, dosi-
metric leaf gap measurements, picket fence test, garden fence
test, testing of leaf positioning accuracy due to carriage move-
ment, calibration of the leaves, leaf speed stability effects
due to acceleration and deceleration of leaves, accuracy and
calibration of leaves in producing complex ﬁelds, effects of
interleaf friction, etc. were all performed.
3.1.  MLC  transmission  factor
The ionization chamber (FC 65G) was placed in a water phan-
tom, ﬁxed at isocenter at a depth of 10 cm,  with a ﬁeld size
of 10 cm × 10 cm.  The monitor response for the open ﬁeld was
recorded. The monitor response for the closed MLC  ﬁeld was
obtained by placing the chamber below the MLC  leaves which
was at an over travel distance of 3 cm from the ﬁeld center.
The same was repeated by moving the other bank of MLC. The
applied voltage was 300 V to the electrometer and the readings
were taken for 6 MV and 15 MV. The MLC transmission factor
is the ratio of meter reading obtained for the closed MLC  ﬁeld
to the meter reading obtained for the open ﬁeld. The mean
reading of the MLC transmission factor of the two banks of
MLC was taken to be the MLC transmission factor. The same
measurements were also done for a ﬁeld size of 20 cm × 20 cm.
esults from ﬁlm dosimetry.
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iFig. 3 – Results for dosime
.2.  DLS  (dosimetric  leaf  separation)eaf transmission and leakage through the rounded leaf ends
s known as dosimetric leaf separation. The ends of the Var-
an MLC  leaves are rounded to achieve acceptable off-axis
Fig. 4 – Result obtained for dosimettest from ﬁlm dosimetry.
dosimetric characteristics while keeping a linear leaf tra-
jectory. Because of the round shape, a signiﬁcant dose is
found between leaves even if the leaf pair is completely
closed. This phenomenon is called the rounded leaf transmis-
sion. The rounded leaf transmission has more  signiﬁcance in
ric test from portal dosimetry.
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e tesFig. 5 – The image obtained for the picket fenc
treatments using dynamic MLC  than in those using a static
MLC  delivery technique. The DLS is the quantity added to the
leaf gap to compute the dose more  accurately, especially for
small gaps. It is used by the leaf motion calculator as an offset
value on leaf position.
Literatures have suggested obtaining the DLS value through
extrapolation to zero of dose plotted as a function of the gap
between opposite leaves. For this, we  ﬁrst measured open ﬁeld
output for a ﬁeld size of 10 cm × 10 cm.  Then transmission
readings for MLC  Bank A and MLC  Bank B were measured. The
ﬁelds with sliding MLC gap of gap sizes 2, 4, 6, 10, 14, 20 mm
were created. The gap moved from −60 mm to +60 mm with
constant speed with respect to MU. The meter readings for
every gap were noted. The corrected gap reading was calcu-
Fig. 6 – The image obtained for the picket fence test at a stationa
Prediction Software.t at a stationary angle on a EDR2 therapy ﬁlm.
lated using transmission for the leaves. A graph was drawn
with gap along the X-axis and corrected gap reading along the
Y-axis. The graph was extrapolated to get the gap required
between opposite leaves to obtain the zero dose.
3.3.  Output  and  linearity  checks  at  different  dose  rates
The ionization chamber was placed in a water phantom at
10 cm depth with a ﬁeld size of 10 cm × 10 cm and 100 cm
SSD. For output measurement, 100 MU was given and moni-
tor response at 300 V for dose rates 100 MU/min, 200 MU/min,
300 MU/min and 400 MU/min were noted. The output at dif-
ferent dose rates were calculated and intercompared. For
ry angle on a EPID and evaluated using the Portal Dose
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uig. 7 – The image obtained for the picket fence test at a stat
inearity veriﬁcation, the monitor response for different MU
ere recorded and compared with the above said dose rates.
.4.  DMLC  QA
MLC QA with different complex ﬁelds were performed to
erify the leaf positioning accuracy, leaf speed, calibration of
eaves, effect on leaf positioning accuracy and leaf speed due
o carriage movement, inter leaf friction, etc. These ﬁelds are
nherently loaded in the treatment console computer by the
endor. Various QA tests were used to verify the mechanical
nd dosimetric stability of the MLC  of the linear accelerator
hen operated in dynamic mode. The mechanical QA test also
eriﬁed the positional accuracy and kinetic properties of the
MLC.
ig. 8 – The image obtained for the picket fence test at a stationa
sing the Portal Dose Prediction Software.ry angle and during gantry rotation on a EDR2 therapy ﬁlm.
4.  Results
4.1.  MLC  transmission  factor,  dosimetric  leaf  gap,
output  and  linearity  checks
The MLC  transmission factor for the Bank A and Bank B were
obtained separately. The obtained transmitted meter readings
were averaged and used to calculate the MLC  transmission
factor. It was found to be 1.39% for 6 MV and 1.7% for 15 MV.
The extrapolated gap to obtain zero dose was found to be
−1.44mm for our 120 leaves DMLC (Fig. 1).The output of the machine measured for different dose
rates 100 MU/min, 200 MU/min, 300 MU/min and 400 MU/min
remained the same with a variation less than ±2%. The lin-
earity checks at different dose rates 100 MU/min, 200 MU/min,
ry angle and during gantry rotation on EPID and evaluated
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Fig. 9 – The image obtained for the picket fence test at a stationary angle and during gantry rotation on EPID and evaluated
using the EPIQA.300 MU/min, and 400 MU/min for MU  ranging from 5 to 400 MU
were verifed and all were found to be linear in the entire range
for the above said dose rates.
4.2.  Routine  DMLC  QA
Routine DMLC QA pattern tests are done to evaluate the sta-
bility and efﬁciency of the MLC  leaves in delivering dynamic
treatments. The tests include picket fence test, garden fence
test, synchronized segmented strip, non-synchronized seg-
mented strip, X Wedge, Y Wedge, pyramid shape, complex
ﬁelds, etc. Picket fence test and garden fence test show the
Fig. 10 – The image obtained for the picket fence test with a sub
The planned error is exactly observed in the image.stability and reproducibility of leaf gap between MLC  leaves
in DMLC mode. The other tests verify the accuracy and cal-
ibration of the leaf position and carriage movement, effects
of interleaf friction on leaf positioning and the ability of the
leaves to interdigitate, leaf speed stability, acceleration and
deceleration, the ability of DMLC leaves to produce complex
intensity modulated pattern, etc. These tests are done using
EDR2 therapy ﬁlms as well as Electronic Portal Imaging Device.
The EPID image  is evaluated using Portal Dose Prediction Soft-
ware  as well as EPIQA. All these test results were satisfactory
conﬁrming the efﬁcient functioning of the DMLC for IMRT
ﬁelds.
 millimeter error introduced taken on EDR2 therapy ﬁlm.
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Table 1 – Results obtained by EPIQA and the deviation
from the reference values is well within the limits for
different gantry angles.
Gantry angle (◦) Deviation from reference value (%)
0 0.402
270 −0.025
90 −0.452
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t
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a
(
Table 2 – Results from EPIQA for accurate control of dose
rate and gantry speed during RapidArc delivery. The
table shows that the deviation between the planned and
delivered dose is well within the acceptable limit of ±2%.
ROI number Deviation from reference value (%)
1 1.57
2 0.36
3 −0.17
4 −0.35
5 −0.66
6 −0.77
7 0.03
(
(
(
F
u
i180 0.075
Reference average value: 0.141 ± 0.00
.3.  DMLC  QA  pertaining  to  rotational  arc  treatments
ach test plays a major role in evaluating the accurate func-
ioning of the MLC  movement, MLC  speed, dose rate variation
nd gantry rotation to deliver the planned dose.
.4.  DMLC  dosimetry
he dose delivered and the dose planned should not vary as
t would lead to overdosage or underdosage to patients. The
MLC dosimetry is done to verify the dose at different gantry
ngles for a dynamic treatment ﬁeld. The deviation between
he calculated and measured dose is tabulated below and one
ould note that the deviation is well within acceptable limits.
he maximum variation in symmetry is only 0.45% and that
n ﬂatness is only 1.06% which is within the 2% acceptable
olerance limit. The dose measured along the x- and y-axes
ormalized to 100% is found to be within 2% in both ﬁlm
osimetry and portal dosimetry. Whereas the dose variation
easured with epiqa had a maximum value of −0.45% and an
verage value of 0.141% (Figs. 2–4 and Table 1).
a) Picket fence test
The picket fence test consists of eight consecutive leaf
movements of 5 cm wide rectangular ﬁelds spaced at 5 cm
intervals. The ﬁeld information is contained in three test
ig. 11 – The image obtained for the picket fence test with a sub 
sing the Portal Dose Prediction Software. As seen above the por
ntroduced in the MLC  position.Reference average value: 0.1509 ± 0.0012
ﬁles, which are run in sequence. These three ﬁles are
exposed in a single ﬁlm. This test is used to verify the
leaf positioning accuracy and also calibrates the carriage
positioning accuracy (Figs. 5 and 6).
It is clear that the dynamic MLC stability and reproducibil-
ity of leaf gap between MLC  leaves are satisfactory.
b) Picket fence test during RapidArc
The above test is repeated at a stationary gantry angle
and during gantry rotation. This test is done to verify the
effect of gantry rotation on the MLC positional accuracy
(Figs. 7–9).
The images obtained show perfectly superimposed images
obtained at a stationary gantry angle and during gantry
rotation with no discrepancies.
c) Picket fence test during RapidArc with intentional errors
This test is to demonstrate that the above test can detect
sub-millimeter errors during RapidArc (Figs. 10–12).
d) Accurate control of dose rate and gantry speed during Rap-
idArc delivery
This test uses 7 combinations of dose-rate, gantry range
and gantry speed to give equal dose to seven 1.8 cm strips
in a RapidArc ﬁeld (Figs. 13 and 14 and Table 2).
millimeter error introduced taken on EPID and evaluated
tal dose image also shows the sub millimeter error
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Fig. 12 – The image obtained for the picket fence test with a sub millimeter error introduced taken on EPID and evaluated
using the EPIQA. Intentional errors introduced in the picket fence pattern were  clearly noticeable.
Fig. 13 – The image taken on EDR2 therapy ﬁlm to evaluate accurate control of dose rate and gantry speed during RapidArc
evaluated with Omnipro software.
( Table 3 – Results from EPIQA for accurate control of leaf
speed during RapidArc delivery, shows that the
deviation between the planned and delivered dose is
well within the acceptable limit of 2%.
ROI number Deviation from reference value (%)
1 0.24
2 0.08
3 −0.74delivery. All the strips show equally exposed regions when 
e) Accurate control of leaf speed during RapidArc delivery
This test uses 4 combinations of leaf speed and dose-rate
to give equal dose to four strips in a RapidArc ﬁeld. The
ﬁlms (both with variable leaf speed and open ﬁeld MLC) are
analyzed and the proﬁles are superimposed to see whether
they are closely matched. The result showed well matched
proﬁles at all leaf speeds and dose rates (Figs. 15 and 16
and Table 3).(f) Record of machine performance during RapidArc
Machine performance during RapidArc was recorded in
two Dynalogs ﬁles. The Clinac control system captures
MU  and gantry angle every ∼50 ms,  and its Dynalog report4 0.43
Reference average value: 7.0852 ± 0.0365
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Fig. 14 – The image taken on EPID and evaluated using the Portal Dose Prediction Software to evaluate accurate control of
dose rate and gantry speed during RapidArc delivery. Even the portal dose shows equal exposures in all strips.
a
t
a
p
r
a
f
o
Fgives comparison of planned gantry angle and cumulative
MU vs. the recorded values. The second Dynalog (from the
MLC  control computer) recorded MLC  positions and gantry
angle every ∼50 ms.
The Dynalog from the Clinac, which recorded gantry angle
nd cumulative MU  at each control point for comparison with
he segmented treatment table, indicated mean standard devi-
tions of ∼0.04 MU  and ∼0.26 MU  for all of the RapidArc QA
lans. The Dynalogs from the MLC  control computer that
ecorded MLC  positions and gantry angle every 50 ms  were
nalyzed. The analysis indicated precise position of all leaves
or the picket fence test. Detectable leaf position errors were
nly present during the motion of the 1-mm strip to the next
ig. 15 – The image obtained on EDR2 therapy ﬁlm to evaluate acposition with speed of ∼2 cm/s. The histogram of >52,000
MLC  positions showed that ∼65% were within 0.05 mm,  ∼3%
between 0.05 and 0.5 mm,  ∼28% between 0.5 and 1 mm,  ∼4%
between 1.0 and 1.5 mm,  and none >1.5 mm.
For another test, the MLC leaves were moved to the next
position with the speed of ∼1 cm/s. The histogram of MLC
position deviations (∼150,000 values) indicated ∼90% of all
errors <0.5 mm.  Analysis of MLC Dynalog ﬁle of Test 3 indi-
cated that leaf position error increased linearly with leaf speed
and was highest when DMLC ran at 2.76 cm/s. Nevertheless,
the histogram showed that ∼87% were within 0.5 mm,  ∼7%
between 0.5 and 1 mm,  ∼4% between 1.0 and 1.5 mm,  ∼2%
>1.5 mm,  and none >2.5 mm.  The proﬁles matched correctly
with very minimal deviation.
curate control of leaf speed during RapidArc delivery.
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Fig. 16 – The image obtained on EPID and evaluated using the Portal Dose Prediction Software to evaluate accurate control of
rleaf speed during RapidArc delivery.
4.5.  RapidArc  delivery  accuracy:
At delivery level, RapidArc plans are transferred by DICOM-
RT communication to the 4D treatment console of the Varian
linear accelerator. Here, the actual treatment parameters are
determined and transferred to the various system controllers.
Particularly, the MLC  controllers verify every 50 ms  the posi-
tion of the leaves with respect to expected, previous and
following positions as well as the agreement of delivered dose.
The linear accelerator controllers check, with the same fre-
quency and logic, the angular position of the gantry and the
dose rate. Whatever discrepancy should be detected by the
controllers would generate immediate beam off interlock and
the delivery would be interrupted.
As per the expectation the result obtained showed that the
RapidArc plans are transferred by DICOM-RT to treatment con-
sole and is delivered as per the plan and the interlock showed
up during the discrepancy.
5.  Conclusion
The delivery of RapidArc requires several advanced techno-
logic capabilities: variable dose rate, variable gantry speed,
and dynamic MLC  during gantry rotation. Commissioning and
acceptance procedures of RapidArc must therefore address
the reliability and accuracy of these parameters. In this study,
we designed procedures to achieve the following: (1) test MLC
positional accuracy, (2) assess the accuracy of variable dose-
rate, and (3) evaluate the accuracy of MLC  leaf speed. The above
tests verify all these parameters and prove that the linear
accelerator is capable of performing RapidArc accurately.
As the measurements are done on ﬁlm as well as EPID
using Omni Pro Accept software for ﬁlm analysation while
PDIP and EPIQA are used to analyze the EPID ﬂuences, themeasurements done in all the three modalities showed the
same results. This proves that the further QA can be done
using EPID.
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